Saturday 17 October 2026
Export NVOS’s income statement to Excel — free account
Novo Integrated Sciences, Inc.
NVOS Healthcare Medical Care Facilities
Novo Integrated Sciences, Inc.’s revenue for fiscal 2024 (year ended August 2024) was $13.3 million, up 5.75% from fiscal 2023. Revenue growth for five consecutive years.
0.00
0.00
NaN
Follow NVOS
Novo Integrated Sciences, Inc. (NVOS) P/E ratio
Novo Integrated Sciences, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 106× (April 2024) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Aug 2024 | 0.0× | — |
| May 2024 | 0.0× | — |
| Feb 2024 | 98.4× | — |
| Nov 2023 | 0.0× | — |
| 29 more quarters | Free account |
Against its own ten years
Low 0.0×
High 106×
Ten-year median
0.0×
Current reading's percentile
98
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NVOS Novo Integrated Sciences, Inc. | n/m |
| CANOQ Cano Health, Inc. compare | n/m |
| BACK IMAC Holdings, Inc. compare | n/m |
| MODVQ ModivCare Inc. compare | n/m |
| IONM Assure Holdings Corp. compare | n/m |
| RHEP Adcare Health Systems Inc compare | 0.6× |
| SYRA Syra Health Corp. compare | 84.0× |
| NIVF NewGenIvf Group Limited compare | — |
| BMGL Basel Medical Group Ltd compare | — |
| Medical Care Facilities industry median | 20.6× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)